or Try an Advanced Search...

    Clinical Trial Stocks List

    Symbol Grade Name % Change
    ICLR D ICON plc 4.76
    BBC D Virtus LifeSci Biotech Clinical Trials ETF -0.79
    INBX F Inhibrx, Inc. 0.14
    MREO F Mereo BioPharma Group plc 1.82
    GLSI F Greenwich LifeSciences, Inc. -0.39
    LQDA F Liquidia Technologies, Inc. 0.99
    VRCA F Verrica Pharmaceuticals Inc. 17.20
    LPCN F Lipocine Inc. 8.07
    TCON F TRACON Pharmaceuticals, Inc. -31.40
    VTGN F VistaGen Therapeutics, Inc. -2.68
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Clinical Research Biotechnology Clinical Development Drug Discovery Medicine Pharmaceutical Breast Cancer Clinical Pharmacology Health Sciences Medication Metabolism Pharmaceutical Products Pharmacology Sarcoma Treatment Of Breast Cancer Acid Age Related Macular Degeneration Alcohol Androstanes

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial stocks.

    Symbol Grade Name Weight
    SURI C Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 6.84
    XPH B SPDR S&P Pharmaceuticals ETF 3.59
    PJP D PowerShares Dynamic Pharmaceuticals 3.47
    PBE D PowerShares Dynamic Biotech & Genome 2.78
    PILL C Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 2.46
    View all Clinical Trial ETFs...
    Compare ETFs
    Compare SURI to PILL Compare SURI to PJP Compare XPH to PBE

        Clinical Trial Stocks Recent News

        Date Stock Title
        Nov 21 ICLR Should You Retain Your Conviction in Icon Plc (ICLR)?
        Nov 21 ICLR Baird cuts Icon target, names ‘Bullish Fresh Pick’
        Nov 19 LQDA 3 US Growth Stocks With At Least 10% Insider Ownership
        Nov 18 LPCN Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
        Nov 17 INBX The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
        Nov 15 ICLR ICON Public Limited Company (ICLR): Among 12 High Growth Large Cap Stocks to Buy Now
        Nov 15 LQDA Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off
        Nov 15 INBX Inhibrx Biosciences GAAP EPS of -$2.84
        Nov 15 LQDA Liquidia Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 ICLR Elliott Investment Management Adds To Southwest, Western Digital, Etsy, Match Group; Trims BILL Holdings, Seadrill, BlackLine, NRG Energy In Q3
        Nov 14 INBX Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Drug Discovery Biotechnology Clinical Research Pain Acute Myeloid Leukemia Autoimmune Disease Biopharmaceutical Cataracts Central Nervous System Disease Chemotherapy Clinical Trial Product Hematological Cancers Infectious Diseases Inflammation Medicine Non Small Cell Lung Cancer Nursing Research Pharmaceutical Product Testing Schizophrenia
        Clinical Trial

        A clinical trial is a research study in which people volunteer to test new treatments, interventions, or tests as a means to prevent, detect, or treat diseases or conditions. Clinical trials are conducted to determine the safety and effectiveness of new drugs, medical devices, or other treatments.

        Browse All Tags